home.social
Sign in Create account

#biotechindustry — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #biotechindustry, aggregated by home.social.

  1. BioResire @[email protected] ·

    Unlock top career opportunities in Bioinformatics with BioResire!
    Leading companies in Bangalore and Hyderabad are hiring skilled professionals.
    Advance your future with the best industry connections and real-world guidance.
    Join BioResire to start your journey toward a successful bioinformatics career!

    #BioinformaticsJobs #DataScience #Genomics #LifeScienceCareers #BioinformaticsTraining #BiotechIndustry #NextGenCareers #STEMEducation #HealthcareIT #ClinicalResearch #DigitalHealth #JobSearch

    #bioinformaticsjobs #datascience #genomics #lifesciencecareers #bioinformaticstraining #biotechindustry
  2. Yonhap Infomax News @[email protected] ·

    Samsung Biologics announces spin-off to separate CDMO and biosimilar businesses, aiming to resolve conflicts of interest and secure growth momentum in both sectors.
    #YonhapInfomax #SamsungBiologics #CDMO #Biosimilars #CorporateRestructuring #BiotechIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #samsungbiologics #cdmo #biosimilars #corporaterestructuring #biotechindustry
  3. Yonhap Infomax News @[email protected] ·

    Samsung Biologics announces spin-off to create Samsung Epis Holdings, sparking market speculation about potential governance restructuring and impacting stock prices of Samsung C&T and Samsung Biologics.
    #YonhapInfomax #SamsungBiologics #SpinOff #SamsungCT #GovernanceRestructuring #BiotechIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #samsungbiologics #spinoff #samsungct #governancerestructuring #biotechindustry
  4. Yonhap Infomax News @[email protected] ·

    Samsung Biologics maintains its financial outlook for the year, indicating stability in its business operations despite recent corporate restructuring
    #YonhapInfomax #SamsungBiologics #FinancialGuidance #CorporateSplit #BiotechIndustry #BusinessOutlook #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #samsungbiologics #financialguidance #corporatesplit #biotechindustry #businessoutlook
  5. Yonhap Infomax News @[email protected] ·

    Samsung Biologics clarifies it is not currently considering an initial public offering for its subsidiary Samsung Bioepis, dispelling market speculation
    #YonhapInfomax #SamsungBiologics #SamsungBioepis #IPO #BiotechIndustry #CorporateStrategy #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #samsungbiologics #samsungbioepis #ipo #biotechindustry #corporatestrategy
  6. Yonhap Infomax News @[email protected] ·

    Samsung Biologics announces corporate restructuring, splitting into two entities to enhance operational efficiency and focus on core business areas
    #YonhapInfomax #SamsungBiologics #CorporateRestructuring #CompanySplit #SamsungEpisHoldings #BiotechIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #samsungbiologics #corporaterestructuring #companysplit #samsungepisholdings #biotechindustry
  7. Yonhap Infomax News @[email protected] ·

    Samsung Biologics announces strategic split, forming separate entities Samsung Biologics and Samsung Epis Holdings to enhance operational focus and market competitiveness
    #YonhapInfomax #SamsungBiologics #CorporateSplit #SamsungEpisHoldings #BiotechIndustry #CorporateRestructuring #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #samsungbiologics #corporatesplit #samsungepisholdings #biotechindustry #corporaterestructuring
  8. Yonhap Infomax News @[email protected] ·

    SK Bioscience reports Q1 operating loss of 15.1 billion won, outperforming market expectations amid challenging biotech landscape
    #YonhapInfomax #SKBioscience #Q1Results #OperatingLoss #BiotechIndustry #FinancialPerformance #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #skbioscience #q1results #operatingloss #biotechindustry #financialperformance
  9. Yonhap Infomax News @[email protected] ·

    ABL Bio secures major $3.4 billion technology transfer deal with GSK for 'Grabody-B' drug development platform, marking second-largest biotech agreement in South Korea
    #YonhapInfomax #ABLBio #GlaxoSmithKline #TechnologyTransfer #GrabodyB #BiotechIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #ablbio #glaxosmithkline #technologytransfer #grabodyb #biotechindustry
  10. Yonhap Infomax News @[email protected] ·

    US biotech firm Terns Pharmaceuticals sees potential 5-fold stock increase on promising obesity drug developments and analyst optimism
    #YonhapInfomax #TernsPharmaceuticals #ObesityDrug #GLP1 #StockForecast #BiotechIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #ternspharmaceuticals #obesitydrug #glp1 #stockforecast #biotechindustry
  11. Yonhap Infomax News @[email protected] ·

    Samsung Biologics and Celltrion report record sales for 2023, while industry watches potential impact of Trump's pharmaceutical tariff considerations
    #YonhapInfomax #SamsungBiologics #Celltrion #RecordSales #BiotechIndustry #TrumpTariffs #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
    en.infomaxai.com/news/articleV

    #yonhapinfomax #samsungbiologics #celltrion #recordsales #biotechindustry #trumptariffs